Lung Kee (Bermuda) Holdings Limited (HK:0255)
:0255
Top Page
Lung Kee (Bermuda) Holdings Limited
(0255)
Select Model
Select Model
Rating:53Neutral
Price Target:
HK$1.50
▼(-9.09% Downside)
Action:ReiteratedDate:01/07/26
The score is held back primarily by weak profitability and declining revenue, plus bearish technicals with negative momentum. Support comes from a solid balance sheet, improving free cash flow, and a very high dividend yield, though the extremely high P/E limits the valuation score.
Positive Factors
Strong Balance Sheet
A high equity ratio and low leverage provide durable financial flexibility: the company can fund operations, absorb shocks, and invest in tooling or capacity without immediate refinancing risks. This underpins long-term stability and supports strategic responses to cyclical downturns.
Negative Factors
Declining Revenue Trend
Sustained revenue decline reduces scale benefits and weakens bargaining power with suppliers. Over months this erodes operating leverage, pressures per-unit margins, and constrains reinvestment capacity, making recovery more difficult without structural market share gains or new product wins.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong Balance Sheet
A high equity ratio and low leverage provide durable financial flexibility: the company can fund operations, absorb shocks, and invest in tooling or capacity without immediate refinancing risks. This underpins long-term stability and supports strategic responses to cyclical downturns.
Read all positive factors
Lung Kee (Bermuda) Holdings Limited (0255) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$944.49M
Dividend Yield14.77%
Average Volume (3M)41.87K
Price to Earnings (P/E)―
Beta (1Y)0.38
Revenue Growth-4.52%
EPS GrowthN/A
CountryHK
Employees3,000
SectorIndustrials
Sector Strength72
IndustryManufacturing - Metal Fabrication
Share Statistics
EPS (TTM)-0.03
Shares Outstanding633,887,300
10 Day Avg. Volume75,200
30 Day Avg. Volume41,866
Financial Highlights & Ratios
PEG Ratio0.62
Price to Book (P/B)0.40
Price to Sales (P/S)0.44
P/FCF Ratio3.54
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Lung Kee (Bermuda) Holdings Limited Business Overview & Revenue Model
Company Description
Lung Kee (Bermuda) Holdings Limited, an investment holding company, manufactures and markets mold bases and related products in the People's Republic of China and internationally. The company was founded in 1975 and is headquartered in Sha Tin, Ho...
How the Company Makes Money
Lung Kee (Bermuda) Holdings Limited generates revenue primarily through the sale of its precision engineering products, which include die-casting components and metal fabrications for different industrial applications. The company benefits from a ...
Lung Kee (Bermuda) Holdings Limited Financial Statement Overview
Summary
Income Statement
45
Neutral
Balance Sheet
65
Positive
Cash Flow
70
Positive
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.46B | 1.55B | 1.45B | 1.60B | 2.27B | 2.06B |
| Gross Profit | 884.46M | 951.69M | 263.90M | 398.00M | 777.07M | 653.19M |
| EBITDA | 154.25M | 148.58M | 56.87M | 180.74M | 472.05M | 367.38M |
| Net Income | 6.69M | -13.67M | -72.43M | 15.81M | 227.84M | 181.08M |
Balance Sheet | ||||||
| Total Assets | 1.89B | 1.97B | 2.09B | 2.30B | 2.75B | 2.75B |
| Cash, Cash Equivalents and Short-Term Investments | 518.08M | 546.65M | 428.76M | 536.64M | 833.59M | 918.62M |
| Total Debt | 6.18M | 7.83M | 6.57M | 9.56M | 9.02M | 14.29M |
| Total Liabilities | 284.60M | 298.08M | 294.22M | 314.90M | 474.46M | 471.25M |
| Stockholders Equity | 1.60B | 1.67B | 1.80B | 1.99B | 2.27B | 2.27B |
Cash Flow | ||||||
| Free Cash Flow | 179.43M | 190.82M | -35.72M | -93.17M | 168.61M | 255.22M |
| Operating Cash Flow | 222.65M | 226.34M | 77.21M | 89.17M | 369.94M | 368.26M |
| Investing Cash Flow | -39.56M | -24.35M | -98.07M | -170.05M | -193.03M | -107.73M |
| Financing Cash Flow | -149.50M | -67.33M | -73.86M | -168.90M | -277.76M | -139.41M |
Lung Kee (Bermuda) Holdings Limited Technical Analysis
Neutral
1.65
Price Trends
1.46
Positive
1.60
Negative
1.57
Negative
Market Momentum
<0.01
Negative
52.92
Neutral
55.56
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0255, the sentiment is Neutral. The current price of 1.65 is above the 20-day moving average (MA) of 1.47, above the 50-day MA of 1.46, and above the 200-day MA of 1.57, indicating a neutral trend. The MACD of <0.01 indicates Negative momentum. The RSI at 52.92 is Neutral, neither overbought nor oversold. The STOCH value of 55.56 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for HK:0255.
Lung Kee (Bermuda) Holdings Limited Peers Comparison
UnderperformOutperform
Sector (63)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | HK$1.39B | 2.76 | 7.82% | 2.71% | 28.78% | 185.71% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | HK$1.38B | 2.31 | 7.83% | 5.09% | 0.51% | 3.74% | |
61 Neutral | HK$4.38B | 11.95 | 18.58% | 1.81% | 10.34% | 3.48% | |
54 Neutral | HK$599.78M | 69.30 | 0.61% | ― | 1.48% | 12.50% | |
53 Neutral | HK$944.49M | -47.78 | -1.44% | 14.77% | -4.52% | ― | |
52 Neutral | HK$263.66M | -2.13 | -4.33% | ― | 10.91% | 11.01% |
* Industrials Sector Average
HK:0255
Lung Kee (Bermuda) Holdings Limited
1.49
0.38
34.23%
HK:0822
Ka Shui International Holdings Limited
0.30
0.05
20.90%
HK:0838
Eva Precision Industrial Holdings Limited
0.80
0.13
20.12%
HK:0929
IPE Group Limited
0.57
0.15
35.71%
HK:1050
Karrie International Holdings Limited
2.10
1.46
228.13%
HK:3816
KFM Kingdom Holdings Ltd.
2.32
2.03
689.12%
Lung Kee (Bermuda) Holdings Limited Corporate Events
Lung Kee Warns of Wider 2025 Loss on Weaker Sales and Property Revaluation Hit
Jan 5, 2026
Lung Kee Group Holdings Limited has issued a profit warning, stating that it expects to post a net loss of at least HK$21 million for the year ended 31 December 2025, widening from the HK$14 million loss recorded a year earlier. The deeper loss is...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.